Leptospira Serovars for Diagnosis of Leptospirosis in Humans and Animals in Africa: Common Leptospira Isolates and Reservoir Hosts

PLoS Negl Trop Dis. 2015 Dec 1;9(12):e0004251. doi: 10.1371/journal.pntd.0004251. eCollection 2015 Dec.

Abstract

The burden of leptospirosis in humans and animals in Africa is higher than that reported from other parts of the world. However, the disease is not routinely diagnosed in the continent. One of major factors limiting diagnosis is the poor availability of live isolates of locally circulating Leptospira serovars for inclusion in the antigen panel of the gold standard microscopic agglutination test (MAT) for detecting antibodies against leptospirosis. To gain insight in Leptospira serovars and their natural hosts occurring in Tanzania, concomitantly enabling the improvement of the MAT by inclusion of fresh local isolates, a total of 52 Leptospira isolates were obtained from fresh urine and kidney homogenates, collected between 1996 and 2006 from small mammals, cattle and pigs. Isolates were identified by serogrouping, cross agglutination absorption test (CAAT), and molecular typing. Common Leptospira serovars with their respective animal hosts were: Sokoine (cattle and rodents); Kenya (rodents and shrews); Mwogolo (rodents); Lora (rodents); Qunjian (rodent); serogroup Grippotyphosa (cattle); and an unknown serogroup from pigs. Inclusion of local serovars particularly serovar Sokoine in MAT revealed a 10-fold increase in leptospirosis prevalence in Tanzania from 1.9% to 16.9% in rodents and 0.26% to 10.75% in humans. This indicates that local serovars are useful for diagnosis of human and animal leptospirosis in Tanzania and other African countries.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Africa / epidemiology
  • Agglutination Tests
  • Animals
  • Antibodies, Bacterial / blood*
  • Disease Reservoirs*
  • Humans
  • Kidney / microbiology
  • Leptospira / classification*
  • Leptospira / isolation & purification
  • Leptospirosis / diagnosis*
  • Leptospirosis / microbiology
  • Leptospirosis / veterinary*
  • Mammals
  • Molecular Typing
  • Prevalence
  • Serogroup*
  • Urine / microbiology

Substances

  • Antibodies, Bacterial

Grants and funding

This research was supported by grants from NUFFIC (The Netherlands) through NFP fellowship granted to GFM, funding from the Flemish Inter-university Council (VLIR) (Belgium), the European Union (Ratzooman Project, INCO-Dev ICA4-CT-2002-10056 and StopRats Project EDF FED 2013-330-223), COSTECH (Tanzania) and the International Foundation for Science (IFS: D-4666-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.